Allogene Therapeutics, Inc.
Ticker: ALLO
| Insider | Title |
|---|---|
| Alison Moore | Chief Technical Officer |
| Annie Yoshiyama | SVP, Finance |
| Arie Belldegrun | Director |
| David D Chang | President and CEO, Director |
| Deborah M. Messemer | Director |
| Earl Martin Douglas | SVP, General Counsel |
| Elizabeth A. Barrett | Director |
| Equity Holdings 2 B.v. Pf | 10% or greater ownership |
| Eric Thomas Schmidt | Chief Financial Officer |
| Franz B Humer | Director |
| Geoffrey M. Parker | CHIEF FINANCIAL OFFICER |
| Gp A, Llc Tpg | Former 10% Owner and Director |
| Jon Winkelried | Former 10% Owner and Director |
| Joshua A Kazam | Director |
| Lillian Smith | VP, Corporate Counsel |
| Owen N. Witte | Director |
| Rafael Amado | EVP of RD |
| Stephen Mayo | Director |
| Timothy L. Moore | Chief Technical Officer |
| Veer Bhavnagri | General Counsel |
| Vicki L Sato | Director |
| Zachary Roberts | EVP of RD |